Salience Clinical Introduces S2G Framework Pairing AI Screening with Physician-Executive GestaltSubmissions

New methodology provides biopharma and medtech sponsors an auditable path from multimodal clinical data entropy to regulatory-ready narratives. PRINCETON, N.J., United States, 15th Sep 2026 –  Salience Clinical, LLC, a clinical development and regulatory advisory consultancy, today announced the launch… Continue Reading